| Drug Name |
Sevelamer |
| Drug ID |
BADD_D02012 |
| Description |
Sevelamer is a phosphate binding drug used to prevent hyperphosphataemia in patients with chronic renal failure. It is marketed by Genzyme under the trade name Renagel. |
| Indications and Usage |
For the control of serum phosphorus in patients with Chronic Kidney Disease (CKD) on hemodialysis. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
V03AE02 |
| DrugBank ID |
DB00658
|
| KEGG ID |
D08512
|
| MeSH ID |
D000069603
|
| PubChem ID |
3085017
|
| TTD Drug ID |
D03MZQ
|
| NDC Product Code |
Not Available |
| Synonyms |
Sevelamer | GT335-012 | GT335 012 | GT335012 | Sevelamer Hydrochloride | Hydrochloride, Sevelamer | RenaGel | Sevelamer Carbonate | Carbonate, Sevelamer |
